2002, Number 4
PDF size: 38.47 Kb.
ABSTRACTObjective: To inform on the first nine renal transplants performed in the state of Tamaulipas, Mexico, during a 10 years period.
Design: Retrospective, observational study.
Setting: Private hospital.
Patients and methods: From 1989 to 1999, nine renal transplants were performed from living donors. Patients have been followed until the end of 2000. All patients, recipients and donors, were included in a pretransplant assessment protocol. The following variables were analyzed: etiology of the renal failure, histocompatibility, surgical procedure, immunosuppression, results, complications, and follow-up.
Results: Nine men were transplanted, none had received a previous graft, six received the graft from a related living donor, and three from a living, emotionally related donor. The two main causes for the end-stage chronic renal failure were glomerulonephritis and diabetic glomerulosclerosis. Six were under a hemodialysis regime and three under a peritoneal dialysis regime. Mean age was of 49 years, ranging from 29 to 71. Morbidity consisted mainly in infection of the urinary tract and graft rejection; survival ranged from 1 month to 12 years 7 months. Three patients have died.
Conclusion: Renal transplant is the best therapeutic option for end-stage chronic renal failure.
Murray JE, Merrill JP, Harrison JH. Kidney transplantation between seven pairs of identical twins. Ann Surg 1958; 148: 343-359; discussion 357-9.
Quijano NM, Gómez Mont F, Ortiz Quezada F, Ronces R. Primeras experiencias de trasplante renal en humanos. Gac Med Méx 1964; 94: 93-102.
Simmons RL, Najarian JS. Kidney transplantation. In: Simmons RL, Finch ME, Escher NL, Najarian JS. Comprehensive Manuals of Surgical Specialties; Manual of Vascular Access, Organ Donation & Transplantation. Springer Verlag, New York, 1984; 292.
Carpenter CB, Strom TB. Transplantation: Immunogenetic and clinical aspects-Part I. Hosp Prac (Off Ed) 1982; 17: 125-34.
Ting A, Williams KA, Morris PJ. HLA-DR matching and B Cell crossmatching in renal transplantation. Transplant Proc 1980; 12: 495-501.
Valente JF, Alexander JW. Immunobiology of renal transplantation. Surg Clin North Am 1998; 78: 1-26.
Alarif L, Rodríguez R, Blackburn S, Light JA. Influence of pretransplant antibodies on early renal allograft rejection. Transplant Proc 1987; 19(1 p +1): 771-2.
Melchor JL, Gracida C, Sanmartin MA, Rucker I, Cancino J. Trasplante renal con donador vivo emocionalmente relacionado (N = 36). Nefrol Mex 1998; 19: 151-3.
Strom TB. Immunosuppressive agents in renal transplantation. Kidney Int 1984; 26: 353-65.
First MR. Clinical application of immunosuppressive agents in renal transplantation. Surg Clin North Am 1998; 78: 61-76.
Light JA, Aquino A, Ali A, Rodríguez R, Ali S. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality. Trasplant Proc 1987; 19(1 p+3): 1927-30.
Heil J. Organ Preservation, Transportation, and Sharing. In: Simmons RL, Finch ME, Escher NL, Najarian JS. Comprehensive Manuals of Surgical Specialties; Manual of Vascular Access, Organ Donation & Transplantation. Springer Verlag, New York, 1984; 174.
Sia IG, Paya CU. Infections complications following renal transplantation. Surg Clin North Am 1998; 78: 95-112.
Odland MD. Surgical technique post transplant surgical complications. Surg Clin North Am 1998; 78: 55-60.
Rao VK. Posttransplant medical complications. Surg Clin North Am 1998; 78: 113-32.
Suthanthivan M, Strom TB. Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 1998; 78: 77-94.
Rodríguez-Quilantan FJ, Toledo-Pereyra LH, Suzuki S. Necrosis tubular aguda en el riñón trasplantado. Nefrol Mex 1993; 14: 59-64.
Cecka M. Clinical outcome of renal transplantation. Factors influencing patient and graft survival. Surg Clin North Am 1998; 78: 133-48.